Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight ...

Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." ...

The FDA granted approval for the GLP-1 dosage in just 54 days. The Wegovy pill, rather than injections, was approved in ...

A surprising new study suggests that a drug first designed for brain and blood diseases might also help people lose weight ...

Structure Therapeutics' oral obesity drug aleniglipron delivered up to 16.3% weight loss when ​compared with a placebo after ...

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy. Ozempic has been a household name for ...

Analysts remain intrigued by aleniglipron’s potential in the oral GLP-1RA market, though they note it is too early to compare ...

Structure Therapeutics disclosed that its daily obesity pill led patients to lose about 16% of their body weight relative to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

NEW DELHI- The dramatic rise in diabetes and obesity among Indians is being driven by rapidly changing eating habits marked by a high intake of carbohydrates and saturated fat, alongside low protein ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...